The FDA gave approval to Nidek Inc. to distribute commercially within the United States the company's advanced 200 Hz Eye Tracker for use with the EC-5000 excimer laser system.
Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
4DMT presents data from phase 1/2 PRISM clinical trial and outlines 4FRONT phase 3 study
Advancing the optimal diagnosis & treatment of thyroid eye disease
Ripple Therapeutics and AbbVie collaborate in development of RTC-620 for IOP reduction in patients with open-angle glaucoma
Transforming the eye with a new standard for corneal cross-linking